This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings by this filer, out of 9. Reading the whole list, and the company page behind every filing, is part of the subscription. So are this filer’s key figures — how many filings and open-market buys they reported, and over which period — the price beside each line, and the measured buy-following figure where there is one. What that costs is on the pricing page.
The most recent filings
5 of 9On an award the register reports a price of 0: nothing was paid, and the Quantity column shows the size.
| Company | Transaction | Reported |
|---|---|---|
| Pharming Group N.V.Chief Business Officer | Open-market buy€45,500quantity 50,000 | Aug 13, 2026 |
| Pharming Group N.V.Chief Business Officer | Option exercisenothing paidquantity 100,000 | Apr 3, 2026 |
| Pharming Group N.V.Chief Business Officer | Administrativenothing paidquantity 50,500 | Apr 3, 2026 |
| Pharming Group N.V.Chief Business Officer | Option exercisenothing paidquantity 583,879 | Mar 18, 2026 |
| Pharming Group N.V.Chief Business Officer | Option exercisenothing paidquantity 251,132 | Mar 18, 2026 |